Hb values (cutoff 12.45 g/dL) at the last week of radiation therapy was an independent prognostic factor for overall survival, failure-free survival and loco-regional failure-free survival in nasopharyngeal carcinoma patients [36]. The gene discussed is GSTM1; the disease is nasopharyngeal carcinoma.